Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.25.4540PMID 20679598PMCID PMC2940396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of Glucarpidase in Subjects With Normal and Impaired Renal Function

  2008cited by this paper
• Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.

  2008cited by this paper
• Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.

  2007cited by this paper
• Severe methotrexate toxicity precipitated by intravenous radiographic contrast.

  2007cited by this paper
• Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.

  2007cited by this paper
• Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

  2006cited by this paper
• Understanding and managing methotrexate nephrotoxicity.

  2006cited by this paper
• Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

  2005cited by this paper
• Interactions of carboxypeptidase G2 with 6S-leucovorin and 6R-leucovorin in vitro: implications for the application in case of methotrexate intoxications

  2005cited by this paper
• Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

  2004cited by this paper
• Optimal Management of Methotrexate Intoxication in a Child with Osteosarcoma

  2004cited by this paper
• Carboxypeptidase-G 2 Rescue in Cancer Patients with Delayed Methotrexate Elimination after High-dose Methotrexate Therapy

  2002cited by this paper
• [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].

  2000cited by this paper
• Carboxypeptidase-G2-Rescue bei einer Patientin mit Methotrexat-induziertem Nierenversagen

  2000cited by this paper
• Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.

  2000cited by this paper
• Carboxypeptidase G2 Rescue in Delayed Methotrexate Elimination in Renal Failure

  2000cited by this paper
• Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.

  1999cited by this paper
• Delayed methotrexate clearance in a patient with sickle cell anemia and osteosarcoma.

  1999cited by this paper
• Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.

  1999cited by this paper
• Sauvetage de l'intoxication au méthotrexate par la carboxypeptidase-G2.

  1998cited by this paper
• [Carboxypeptidase-G2 rescue of methotrexate intoxication].

  1998cited by this paper
• Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.

  1997cited by this paper
• Carboxypeptidase‐G2 rescue in a patient with high dose methotrexate‐induced nephrotoxicity

  1995cited by this paper
• Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure.

  1995cited by this paper
• Successful carboxypeptidase G2 rescue in delayed MTX-elimination due to renal failure.

  1995cited by this paper
• Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.

  1992cited by this paper
• High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity.

  1980cited by this paper
• Thymidine requirements for the rescue of patients treated with high-dose methotrexate.

  1980cited by this paper
• Methotrexate: clinical pharmacology, current status and therapeutic guidelines.

  1977cited by this paper

• Validation of the MTXPK Tool in Predicting Glucarpidase Utilization Among Patients With Delayed Methotrexate Clearance: A Retrospective Study.

  2026cites this paper
• High-dose methotrexate nephrotoxicity.

  2025cites this paper
• Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injury.

  2025cites this paper
• High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry

  2025cites this paper
• Glucarpidase for Treatment of High-Dose Methotrexate Toxicity.

  2025cites this paper
• Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate

  2025cites this paper
• Improved analysis HPLC-ESI/triple method for mapping the methotrexate by mass spectrometry.

  2025cites this paper
• Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia

  2025influential citation
• RETRACTED ARTICLE: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid

  2025cites this paper
• Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma

  2025cites this paper
• Case Report: Effective methotrexate removal by combined hemodialysis and polymeric resin hemoadsorption

  2025cites this paper
• Nephrotoxicity of Conventional Chemotherapeutics: Part I - Platinum Compounds and Antimetabolite Agents.

  2025cites this paper
• Safety and Efficiency of Ambulatory High-dose Methotrexate Administration among Hematological Malignancy Patients in a Tertiary Care Center

  2025cites this paper
• Methotrexate-induced neurotoxicity in oncology: Current issues for a classic drug.

  2025cites this paper
• Methotrexate and glucarpidase: the emperor has new clothes.

  2025cites this paper
• Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches

  2024cites this paper
• Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma

  2024cites this paper
• Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases

  2024cites this paper
• Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing

  2024cites this paper
• Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma

  2024cites this paper
• Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study

  2024cites this paper
• Empagliflozin mitigates methotrexate-induced nephrotoxicity in male albino rats: insights on the crosstalk of AMPK/Nrf2 signaling pathway

  2024cites this paper
• Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase

  2024cites this paper
• Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma

  2024cites this paper
• Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase

  2024cites this paper
• Molecular bowls for inclusion complexation of toxic anticancer drug methotrexate

  2024cites this paper
• Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy

  2024cites this paper
• Platelet Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Mitigate Methotrexate-Induced Nephrotoxicity in Rat via Nrf2/Pparγ/HO-1 and NF-Κb/Keap1/Caspase-3 Signaling Pathways: Oxidative Stress and Apoptosis Interplay

  2023influential citation
• Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review

  2023cites this paper
• The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity – a review of pharmacological and clinical data

  2023cites this paper
• Use of glucarpidase (carboxypeptidase‐G2) in pediatric cancer patients: 11‐year experience of a tertiary center

  2023cites this paper
• Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients

  2023cites this paper
• Methotrexate Drug Monitoring From Central Access: Can Blood Sample Collection From Central Venous Access Replace Peripheral Venipuncture in Adults?

  2023cites this paper
• Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy.

  2023cites this paper
• A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials

  2023cites this paper
• Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration‐induced nephropathy

  2023cites this paper
• Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis

  2023cites this paper
• A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity

  2023cites this paper
• Severe Methotrexate Toxicity Following a Capizzi Cycle in an Obese Adolescent With Acute Lymphoblastic Leukemia and Hepatic Steatosis.

  2023cites this paper
• Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis

  2023cites this paper
• High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course

  2022cites this paper
• Real-Time, Seconds-Resolved Measurements of Plasma Methotrexate In Situ in the Living Body.

  2022cites this paper
• Genetic regulation of cytokine inflammation in oncohematological diseases

  2022cites this paper
• Extracorporeal Treatment for Methotrexate Poisoning

  2022cites this paper
• Strategies to mitigate the toxicity of cancer therapeutics.

  2022cites this paper
• Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

  2022cites this paper
• Toxicity associated with high-dose intravenous methotrexate for hematological malignancies

  2022cites this paper
• Acute Kidney Injury in Critically Ill Patients with Cancer.

  2022cites this paper
• Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase.

  2022cites this paper
• Methotrexate nephrotoxicity in a patient with preserved renal function. Case report

  2022cites this paper
• Finding appropriate signal peptides for secretory production of recombinant glucarpidase: an in silico method.

  2021cites this paper
• Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series.

  2021cites this paper
• A rapid LC-MS/MS assay for the measurement of serum methotrexate in patients who have received high doses for chemotherapy

  2021cites this paper
• Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications.

  2021cites this paper
• Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury

  2021cites this paper
• Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury

  2021influential citation
• Treatment of acute kidney injury in cancer patients

  2021cites this paper
• Begleittherapie bei Methotrexat

  2021cites this paper
• Conventional Chemotherapy Nephrotoxicity.

  2021cites this paper
• A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?

  2020cites this paper
• Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota.

  2020cites this paper
• Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage

  2020cites this paper
• Management of methotrexate toxicity

  2020cites this paper
• Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients

  2020cites this paper
• Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia

  2020cites this paper
• Nutritional Influences on Methylation

  2020cites this paper
• Commentary

  2020cites this paper
• MTXPK.org: A Clinical Decision Support Tool Evaluating High‐Dose Methotrexate Pharmacokinetics to Inform Post‐Infusion Care and Use of Glucarpidase

  2020cites this paper
• Preventive strategies for acute kidney injury in cancer patients

  2020cites this paper
• Conventional chemotherapy

  2020cites this paper
• The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation

  2020cites this paper
• A Review of Antineoplastic Agents Associated Nephrotoxicity, an Understood Complication

  2020cites this paper
• Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma.

  2020cites this paper
• Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients

  2019cites this paper
• High-dose Methotrexate

  2019cites this paper
• DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity

  2019cites this paper
• Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study

  2019influential citation
• High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best?

  2019cites this paper
• Recherche de facteurs de risque de toxicité du méthotrexate haute dose chez les patients adultes traités pour une hémopathie lymphoïde

  2019cites this paper
• Renal Function and Plasma Methotrexate Concentrations Predict Toxicities in Adults Receiving High-Dose Methotrexate

  2018cites this paper
• Management of Patients with Acute Methotrexate Nephrotoxicity with High‐Dose Leucovorin

  2018cites this paper
• Drug-Induced Acute Kidney Injury

  2018cites this paper
• Selective Cell Penetrating Peptide‐Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo

  2018cites this paper
• [Renal toxicity of high-dose methotrexate].

  2018cites this paper
• Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.

  2018cites this paper
• High incidence of acute kidney injury during chemotherapy for childhood acute myeloid leukemia

  2018cites this paper
• Acute Kidney Injury and Cancer: Incidence, Pathophysiology, Prevention/Treatment, and Outcomes

  2018cites this paper
• A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities

  2018cites this paper
• Working Through the Paradox of Methotrexate Toxicity.

  2018cites this paper
• Glucarpidase for methotrexate nephrotoxicity: another string to our bow

  2017cites this paper
• Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels

  2017cites this paper
• Prevention of Chemotherapy-Induced Nephrotoxicity in Children with Cancer

  2017cites this paper
• Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity

  2017cites this paper
• Recovery of methotrexate-induced anuric acute kidney injury after glucarpidase therapy

  2017cites this paper
• Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

  2017cites this paper
• Guidelines for treatment of renal injury during cancer chemotherapy 2016

  2017cites this paper
• What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?

  2017cites this paper
• Alendronate sodium‐induced interstitial nephritis

  2017cites this paper
• Critical Care Toxicology

  2017cites this paper
• Delayed elimination of high‐dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia

  2017cites this paper